help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, K.
Right arrow Articles by Akagi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, K.
Right arrow Articles by Akagi, T.
(American Journal of Pathology. 2001;158:1533-1542.)
© 2001 American Society for Investigative Pathology


Animal Model

An Animal Model for Human EBV-Associated Hemophagocytic Syndrome

Herpesvirus Papio Frequently Induces Fatal Lymphoproliferative Disorders with Hemophagocytic Syndrome in Rabbits

Kazuhiko Hayashi*, Nobuya Ohara*, Norihiro Teramoto*, Sachiyo Onoda*, Hong-Li Chen*, Takashi Oka*, Eisaku Kondo*, Tadashi Yoshino*, Kiyoshi Takahashi{dagger}, John Yates{ddagger} and Tadaatsu Akagi*

From the Second Department of Pathology,*
Okayama University Medical School, Okayama, Japan; the School of Health Science,{dagger}
Okayama University, Okayama, Japan; and the Department of Human Genetics,{ddagger}
Roswell Park Cancer Institute, Buffalo, New York

Epstein-Barr virus-associated hemophagocytic syndrome (EBV-AHS) is often associated with fatal infectious mononucleosis. However, the animal model for EBV-AHS has not been developed. We reported the first animal model for EBV-AHS using rabbits infected with EBV-related herpesvirus of baboon (HVP). Eleven of 13 (85%) rabbits inoculated intravenously with HVP-producing cells developed fatal lymphoproliferative disorders (LPD) between 22 and 105 days after inoculation. LPD was also accompanied by hemophagocytic syndrome (HPS) in nine of these 11 rabbits. The peroral spray of cell-free HVP induced the virus infection with increased anti-EBV-viral capsid antigen-IgG titers in three of five rabbits, and two of these three infected rabbits died of LPD with HPS. Autopsy revealed hepatosplenomegaly and swollen lymph nodes. Atypical lymphoid T cells expressing EBV-encoded small RNA-1 infiltrated diffusely in many organs, frequently involving the lymph nodes, spleen, and liver. Hemophagocytic histiocytosis was observed in the lymph nodes, spleen, bone marrow, and thymus. HVP-DNA was detected in the tissues and peripheral blood from the infected rabbits by polymerase chain reaction or Southern blot analysis. Reverse transcriptase-polymerase chain reaction revealed both HVP-EBNA1 and HVP-EBNA2 transcripts, suggesting latency type III infection. These data indicate that the high rate of rabbit LPD with HPS induction is caused by HVP. This system is useful for studying the pathogenesis, prevention, and treatment of human EBV-AHS.





This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
W.-C. Hsieh, Y. Chang, M.-C. Hsu, B.-S. Lan, G.-C. Hsiao, H.-C. Chuang, and I.-J. Su
Emergence of Anti-Red Blood Cell Antibodies Triggers Red Cell Phagocytosis by Activated Macrophages in a Rabbit Model of Epstein-Barr Virus-Associated Hemophagocytic Syndrome
Am. J. Pathol., May 1, 2007; 170(5): 1629 - 1639.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Hayashi, Z. Jin, S. Onoda, H. Joko, N. Teramoto, N. Ohara, W. Oda, T. Tanaka, Y.-X. Liu, T. R. Koirala, et al.
Rabbit Model for Human EBV-Associated Hemophagocytic Syndrome (HPS): Sequential Autopsy Analysis and Characterization of IL-2-Dependent Cell Lines Established from Herpesvirus Papio-Induced Fatal Rabbit Lymphoproliferative Diseases with HPS
Am. J. Pathol., May 1, 2003; 162(5): 1721 - 1736.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
U. Emmenegger, P. J. Spaeth, K. A. Neftel, S. Imashuku, T. Teramura, E. Ishii, N. Kinugawa, M. Kato, M. Sako, K. Kuriyama, et al.
Intravenous Immunoglobulin for Hemophagocytic Lymphohistiocytosis?
J. Clin. Oncol., January 15, 2002; 20(2): 599 - 601.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.